Pharmaceuticals Global Industry Almanac 2020-2029

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market size (value , and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.

By disease type, the market is segmented into oncology drugs, anti-infective drugs, central nervous system drugs, cardiovascular disease drugs, dermatology drugs, respiratory drugs, and others. The scope of others includes diabetes drugs, anti-allergic drugs, gastrointestinal drugs, ophthalmic drugs, renal diseases drugs, hematological disorders drugs, infertility conditions drugs, and women's health diseases drugs, etc.

All market data and forecasts are based on nominal prices, and all currency conversions used in the creation of this report have been calculated using yearly average exchange rates. The USD values may show a declining trend for a few countries such as Argentina, Turkey, Nigeria, Egypt, and Russia. This is primarily because of the impact of exchange rates considered.

The global pharmaceuticals market recorded revenues of $1,437.5 billion in 2024, representing a compound annual growth rate (CAGR) of 4.0% between 2019 and 2024.

The oncology drugs segment accounted for the market's largest proportion in 2024, with total revenues of $197.2 billion, equivalent to 13.7% of the market's overall value.

The global pharmaceuticals market witnessed healthy growth in 2024, registering an annual growth of 5.7%.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the global pharmaceuticals market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts

Reasons to Buy

What was the size of the global pharmaceuticals market by value in 2024?
What will be the size of the global pharmaceuticals market in 2029?
What factors are affecting the strength of competition in the global pharmaceuticals market?
How has the market performed over the last five years?
What are the main segments that make up the global pharmaceuticals market?

Product Code: MLIG250084-01

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Competitive landscape

2 Introduction

2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions

3 Global Pharmaceuticals

3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators

4.1. Country data

5 Pharmaceuticals in Asia-Pacific

5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Pharmaceuticals in Europe

6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis

7 Macroeconomic Indicators

7.1. Country data

8 Pharmaceuticals in France

8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis

9 Macroeconomic Indicators

9.1. Country data

10 Pharmaceuticals in Germany

10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis

11 Macroeconomic Indicators

11.1. Country data

12 Pharmaceuticals in Australia

12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis

13 Macroeconomic Indicators

13.1. Country data

14 Pharmaceuticals in Brazil

14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis

15 Macroeconomic Indicators

15.1. Country data

16 Pharmaceuticals in Canada

16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis

17 Macroeconomic Indicators

17.1. Country data

18 Pharmaceuticals in China

18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis

19 Macroeconomic Indicators

19.1. Country data

20 Pharmaceuticals in India

20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis

21 Macroeconomic Indicators

21.1. Country data

22 Pharmaceuticals in Indonesia

22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis

23 Macroeconomic Indicators

23.1. Country data

24 Pharmaceuticals in Italy

24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis

25 Macroeconomic Indicators

25.1. Country data

26 Pharmaceuticals in Japan

26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis

27 Macroeconomic Indicators

27.1. Country data

28 Pharmaceuticals in Mexico

28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis

29 Macroeconomic Indicators

29.1. Country data

30 Pharmaceuticals in The Netherlands

30.1. Market Overview
30.2. Market Data
30.3. Market Segmentation
30.4. Market outlook
30.5. Five forces analysis

31 Macroeconomic Indicators

31.1. Country data

32 Pharmaceuticals in North America

32.1. Market Overview
32.2. Market Data
32.3. Market Segmentation
32.4. Market outlook
32.5. Five forces analysis

33 Pharmaceuticals in Russia

33.1. Market Overview
33.2. Market Data
33.3. Market Segmentation
33.4. Market outlook
33.5. Five forces analysis

34 Macroeconomic Indicators

34.1. Country data

35 Pharmaceuticals in Scandinavia

35.1. Market Overview
35.2. Market Data
35.3. Market Segmentation
35.4. Market outlook
35.5. Five forces analysis

36 Pharmaceuticals in Singapore

36.1. Market Overview
36.2. Market Data
36.3. Market Segmentation
36.4. Market outlook
36.5. Five forces analysis

37 Macroeconomic Indicators

37.1. Country data

38 Pharmaceuticals in South Africa

38.1. Market Overview
38.2. Market Data
38.3. Market Segmentation
38.4. Market outlook
38.5. Five forces analysis

39 Macroeconomic Indicators

39.1. Country data

40 Pharmaceuticals in South Korea

40.1. Market Overview
40.2. Market Data
40.3. Market Segmentation
40.4. Market outlook
40.5. Five forces analysis

41 Macroeconomic Indicators

41.1. Country data

42 Pharmaceuticals in Spain

42.1. Market Overview
42.2. Market Data
42.3. Market Segmentation
42.4. Market outlook
42.5. Five forces analysis

43 Macroeconomic Indicators

43.1. Country data

44 Pharmaceuticals in Turkey

44.1. Market Overview
44.2. Market Data
44.3. Market Segmentation
44.4. Market outlook
44.5. Five forces analysis

45 Macroeconomic Indicators

45.1. Country data

46 Pharmaceuticals in The United Kingdom

46.1. Market Overview
46.2. Market Data
46.3. Market Segmentation
46.4. Market outlook
46.5. Five forces analysis

47 Macroeconomic Indicators

47.1. Country data

48 Pharmaceuticals in The United States

48.1. Market Overview
48.2. Market Data
48.3. Market Segmentation
48.4. Market outlook
48.5. Five forces analysis

49 Macroeconomic Indicators

49.1. Country data

50 Company Profiles

50.1. Johnson & Johnson
50.2. Merck & Co Inc
50.3. AbbVie Inc
50.4. Pfizer Inc
50.5. Sinopharm Group Co Ltd
50.6. Shanghai Pharmaceuticals Holding Co Ltd
50.7. CSPC Pharmaceutical Group Ltd
50.8. Takeda Pharmaceutical Co Ltd
50.9. Novartis AG
50.10. AstraZeneca Plc
50.11. GSK plc
50.12. F. Hoffmann-La Roche Ltd
50.13. Sanofi
50.14. Laboratoires Pierre Fabre SA
50.15. Les Laboratoires Servier SAS
50.16. Ipsen SA
50.17. Bayer AG
50.18. Boehringer Ingelheim International GmbH
50.19. Fresenius Medical Care AG & Co KGaA
50.20. Merck KGaA
50.21. CSL Ltd
50.22. Ramsay Health Care Ltd
50.23. Mayne Pharma Group Ltd
50.24. Ache Laboratorios Farmaceuticos SA
50.25. EMS SA
50.26. Hypera SA
50.27. Eurofarma Laboratorios SA
50.28. Apotex Inc
50.29. Bausch Health Companies Inc
50.30. Jiangsu Hengrui Pharmaceuticals Co Ltd
50.31. Sun Pharmaceutical Industries Ltd
50.32. Lupin Ltd
50.33. Cipla Ltd
50.34. Dr. Reddy's Laboratories Ltd
50.35. PT Kimia Farma Tbk
50.36. PT Kalbe Farma Tbk
50.37. PT Tempo Scan Pacific Tbk
50.38. A. Menarini Industrie Farmaceutiche Riunite Srl
50.39. Recordati SpA
50.40. Chiesi Farmaceutici SpA
50.41. Astellas Pharma Inc
50.42. Daiichi Sankyo Co Ltd
50.43. Otsuka Holdings Co Ltd
50.44. Genomma Lab Internacional SAB de CV
50.45. Pharmstandard
50.46. Binnopharm Group
50.47. OTC Pharma International BV
50.48. H. Lundbeck AS
50.49. Novo Nordisk AS
50.50. Aspen Pharmacare Holdings Ltd
50.51. Adcock Ingram Holdings Ltd
50.52. Chong Kun Dang Pharmaceutical Corp.
50.53. Hanmi Pharmaceuticals Co Ltd
50.54. Celltrion Inc
50.55. Yuhan Corp
50.56. Almirall SAS
50.57. Grifols SA
50.58. Laboratorios Farmaceuticos Rovi SA
50.59. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
50.60. Deva Holding AS

51 Appendix

51.1. Methodology
51.2. About MarketLine

Product Code: MLIG250084-01

List of Tables

Table 1: Global pharmaceuticals market value: $ million, 2019-24
Table 2: Global pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: Global pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: Global pharmaceuticals market geography segmentation: $ million, 2024
Table 5: Global pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Global Size of Population (Million), 2020-24
Table 7: Global Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 8: Global GDP (Current Prices, $ Billion), 2020-24
Table 9: Global Inflation, 2020-24
Table 10: Global Consumer Price Index (Absolute), 2020-24
Table 11: Global Exchange Rate, 2019-24
Table 12: Asia-Pacific pharmaceuticals market value: $ million, 2019-24
Table 13: Asia-Pacific pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 14: Asia-Pacific pharmaceuticals market category segmentation: $ million, 2019-24
Table 15: Asia-Pacific pharmaceuticals market geography segmentation: $ million, 2024
Table 16: Asia-Pacific pharmaceuticals market value forecast: $ million, 2024-29
Table 17: Europe pharmaceuticals market value: $ million, 2019-24
Table 18: Europe pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 19: Europe pharmaceuticals market category segmentation: $ million, 2019-24
Table 20: Europe pharmaceuticals market geography segmentation: $ million, 2024
Table 21: Europe pharmaceuticals market value forecast: $ million, 2024-29
Table 22: Europe Size of Population (Million), 2020-24
Table 23: Europe Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 24: Europe GDP (Current Prices, $ Billion), 2020-24
Table 25: Europe Inflation, 2020-24
Table 26: Europe Consumer Price Index (Absolute), 2020-24
Table 27: Europe Exchange Rate, 2019-24
Table 28: France pharmaceuticals market value: $ million, 2019-24
Table 29: France pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 30: France pharmaceuticals market category segmentation: $ million, 2019-24
Table 31: France pharmaceuticals market geography segmentation: $ million, 2024
Table 32: France pharmaceuticals market value forecast: $ million, 2024-29
Table 33: France Size of Population (Million), 2020-24
Table 34: France Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 35: France GDP (Current Prices, $ Billion), 2020-24
Table 36: France Inflation, 2020-24
Table 37: France Consumer Price Index (Absolute), 2020-24
Table 38: France Exchange Rate, 2019-24
Table 39: Germany pharmaceuticals market value: $ million, 2019-24
Table 40: Germany pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 41: Germany pharmaceuticals market category segmentation: $ million, 2019-24
Table 42: Germany pharmaceuticals market geography segmentation: $ million, 2024
Table 43: Germany pharmaceuticals market value forecast: $ million, 2024-29
Table 44: Germany Size of Population (Million), 2020-24
Table 45: Germany Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 46: Germany GDP (Current Prices, $ Billion), 2020-24
Table 47: Germany Inflation, 2020-24
Table 48: Germany Consumer Price Index (Absolute), 2020-24
Table 49: Germany Exchange Rate, 2019-24
Table 50: Australia pharmaceuticals market value: $ million, 2019-24
Table 51: Australia pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 52: Australia pharmaceuticals market category segmentation: $ million, 2019-24
Table 53: Australia pharmaceuticals market geography segmentation: $ million, 2024
Table 54: Australia pharmaceuticals market value forecast: $ million, 2024-29
Table 55: Australia Size of Population (Million), 2020-24
Table 56: Australia Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 57: Australia GDP (Current Prices, $ Billion), 2020-24
Table 58: Australia Inflation, 2020-24
Table 59: Australia Consumer Price Index (Absolute), 2020-24
Table 60: Australia Exchange Rate, 2019-24
Table 61: Brazil pharmaceuticals market value: $ million, 2019-24
Table 62: Brazil pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 63: Brazil pharmaceuticals market category segmentation: $ million, 2019-24
Table 64: Brazil pharmaceuticals market geography segmentation: $ million, 2024
Table 65: Brazil pharmaceuticals market value forecast: $ million, 2024-29
Table 66: Brazil Size of Population (Million), 2020-24
Table 67: Brazil Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 68: Brazil GDP (Current Prices, $ Billion), 2020-24
Table 69: Brazil Inflation, 2020-24
Table 70: Brazil Consumer Price Index (Absolute), 2020-24
Table 71: Brazil Exchange Rate, 2019-24
Table 72: Canada pharmaceuticals market value: $ million, 2019-24
Table 73: Canada pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 74: Canada pharmaceuticals market category segmentation: $ million, 2019-24
Table 75: Canada pharmaceuticals market geography segmentation: $ million, 2024
Table 76: Canada pharmaceuticals market value forecast: $ million, 2024-29
Table 77: Canada Size of Population (Million), 2020-24
Table 78: Canada Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 79: Canada GDP (Current Prices, $ Billion), 2020-24
Table 80: Canada Inflation, 2020-24
Table 81: Canada Consumer Price Index (Absolute), 2020-24
Table 82: Canada Exchange Rate, 2019-24
Table 83: China pharmaceuticals market value: $ million, 2019-24
Table 84: China pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 85: China pharmaceuticals market category segmentation: $ million, 2019-24
Table 86: China pharmaceuticals market geography segmentation: $ million, 2024
Table 87: China pharmaceuticals market value forecast: $ million, 2024-29
Table 88: China Size of Population (Million), 2020-24
Table 89: China Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 90: China GDP (Current Prices, $ Billion), 2020-24
Table 91: China Inflation, 2020-24
Table 92: China Consumer Price Index (Absolute), 2020-24
Table 93: China Exchange Rate, 2019-24
Table 94: India pharmaceuticals market value: $ million, 2019-24
Table 95: India pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 96: India pharmaceuticals market category segmentation: $ million, 2019-24
Table 97: India pharmaceuticals market geography segmentation: $ million, 2024
Table 98: India pharmaceuticals market value forecast: $ million, 2024-29
Table 99: India Size of Population (Million), 2020-24
Table 100: India Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 101: India GDP (Current Prices, $ Billion), 2020-24
Table 102: India Inflation, 2020-24
Table 103: India Consumer Price Index (Absolute), 2020-24
Table 104: India Exchange Rate, 2019-24
Table 105: Indonesia pharmaceuticals market value: $ million, 2019-24
Table 106: Indonesia pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 107: Indonesia pharmaceuticals market category segmentation: $ million, 2019-24
Table 108: Indonesia pharmaceuticals market geography segmentation: $ million, 2024
Table 109: Indonesia pharmaceuticals market value forecast: $ million, 2024-29
Table 110: Indonesia Size of Population (Million), 2020-24

List of Figures

Figure 1: Global pharmaceuticals market value: $ million, 2019-24
Figure 2: Global pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: Global pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: Global pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the global pharmaceuticals market, 2024
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2024
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2024
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2024
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2024
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2024
Figure 11: Asia-Pacific pharmaceuticals market value: $ million, 2019-24
Figure 12: Asia-Pacific pharmaceuticals market category segmentation: $ million, 2019-24
Figure 13: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ million, 2024-29
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2024
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2024
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2024
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2024
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2024
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2024
Figure 21: Europe pharmaceuticals market value: $ million, 2019-24
Figure 22: Europe pharmaceuticals market category segmentation: $ million, 2019-24
Figure 23: Europe pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 24: Europe pharmaceuticals market value forecast: $ million, 2024-29
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2024
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2024
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2024
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2024
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2024
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2024
Figure 31: France pharmaceuticals market value: $ million, 2019-24
Figure 32: France pharmaceuticals market category segmentation: $ million, 2019-24
Figure 33: France pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 34: France pharmaceuticals market value forecast: $ million, 2024-29
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2024
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2024
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2024
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2024
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2024
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2024
Figure 41: Germany pharmaceuticals market value: $ million, 2019-24
Figure 42: Germany pharmaceuticals market category segmentation: $ million, 2019-24
Figure 43: Germany pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 44: Germany pharmaceuticals market value forecast: $ million, 2024-29
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2024
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2024
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2024
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2024
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2024
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2024
Figure 51: Australia pharmaceuticals market value: $ million, 2019-24
Figure 52: Australia pharmaceuticals market category segmentation: $ million, 2019-24
Figure 53: Australia pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 54: Australia pharmaceuticals market value forecast: $ million, 2024-29
Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2024
Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2024
Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2024
Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2024
Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2024
Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2024
Figure 61: Brazil pharmaceuticals market value: $ million, 2019-24
Figure 62: Brazil pharmaceuticals market category segmentation: $ million, 2019-24
Figure 63: Brazil pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 64: Brazil pharmaceuticals market value forecast: $ million, 2024-29
Figure 65: Forces driving competition in the pharmaceuticals market in Brazil, 2024
Figure 66: Drivers of buyer power in the pharmaceuticals market in Brazil, 2024
Figure 67: Drivers of supplier power in the pharmaceuticals market in Brazil, 2024
Figure 68: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2024
Figure 69: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2024
Figure 70: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2024
Figure 71: Canada pharmaceuticals market value: $ million, 2019-24
Figure 72: Canada pharmaceuticals market category segmentation: $ million, 2019-24
Figure 73: Canada pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 74: Canada pharmaceuticals market value forecast: $ million, 2024-29
Figure 75: Forces driving competition in the pharmaceuticals market in Canada, 2024
Figure 76: Drivers of buyer power in the pharmaceuticals market in Canada, 2024
Figure 77: Drivers of supplier power in the pharmaceuticals market in Canada, 2024
Figure 78: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2024
Figure 79: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2024
Figure 80: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2024
Figure 81: China pharmaceuticals market value: $ million, 2019-24
Figure 82: China pharmaceuticals market category segmentation: $ million, 2019-24
Figure 83: China pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 84: China pharmaceuticals market value forecast: $ million, 2024-29
Figure 85: Forces driving competition in the pharmaceuticals market in China, 2024
Figure 86: Drivers of buyer power in the pharmaceuticals market in China, 2024
Figure 87: Drivers of supplier power in the pharmaceuticals market in China, 2024
Figure 88: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2024
Figure 89: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2024
Figure 90: Drivers of degree of rivalry in the pharmaceuticals market in China, 2024
Figure 91: India pharmaceuticals market value: $ million, 2019-24
Figure 92: India pharmaceuticals market category segmentation: $ million, 2019-24
Figure 93: India pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 94: India pharmaceuticals market value forecast: $ million, 2024-29
Figure 95: Forces driving competition in the pharmaceuticals market in India, 2024
Figure 96: Drivers of buyer power in the pharmaceuticals market in India, 2024
Figure 97: Drivers of supplier power in the pharmaceuticals market in India, 2024
Figure 98: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2024
Figure 99: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2024
Figure 100: Drivers of degree of rivalry in the pharmaceuticals market in India, 2024

Pharmaceuticals Global Industry Almanac 2020-2029

Description

Table of Contents

List of Tables

Summary

Key Highlights

Scope

Reasons to Buy

Table of Contents

1 EXECUTIVE SUMMARY

2 Introduction

3 Global Pharmaceuticals

4 Macroeconomic Indicators

5 Pharmaceuticals in Asia-Pacific

6 Pharmaceuticals in Europe

7 Macroeconomic Indicators

8 Pharmaceuticals in France

9 Macroeconomic Indicators

10 Pharmaceuticals in Germany

11 Macroeconomic Indicators

12 Pharmaceuticals in Australia

13 Macroeconomic Indicators

14 Pharmaceuticals in Brazil

15 Macroeconomic Indicators

16 Pharmaceuticals in Canada

17 Macroeconomic Indicators

18 Pharmaceuticals in China

19 Macroeconomic Indicators

20 Pharmaceuticals in India

21 Macroeconomic Indicators

22 Pharmaceuticals in Indonesia

23 Macroeconomic Indicators

24 Pharmaceuticals in Italy

25 Macroeconomic Indicators

26 Pharmaceuticals in Japan

27 Macroeconomic Indicators

28 Pharmaceuticals in Mexico

29 Macroeconomic Indicators

30 Pharmaceuticals in The Netherlands

31 Macroeconomic Indicators

32 Pharmaceuticals in North America

33 Pharmaceuticals in Russia

34 Macroeconomic Indicators

35 Pharmaceuticals in Scandinavia

36 Pharmaceuticals in Singapore

37 Macroeconomic Indicators

38 Pharmaceuticals in South Africa

39 Macroeconomic Indicators

40 Pharmaceuticals in South Korea

41 Macroeconomic Indicators

42 Pharmaceuticals in Spain

43 Macroeconomic Indicators

44 Pharmaceuticals in Turkey

45 Macroeconomic Indicators

46 Pharmaceuticals in The United Kingdom

47 Macroeconomic Indicators

48 Pharmaceuticals in The United States

49 Macroeconomic Indicators

50 Company Profiles

51 Appendix

List of Tables

List of Figures